Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.
Rep. June Speakman
Sponsored bills
Maddy summaryHB 5620 regulates prescription drug price increases in Rhode Island by imposing penalties on manufacturers who raise prices without supporting medical evidence. It targets drugs identified as having "unsupported price increases" through the Institute for Clinical and Economic Review (ICER) annual report. Manufacturers with over $250,000 in annual sales within the state face a penalty equal to 80% of the revenue difference between actual sales and what would have been earned at the previous year’s wholesale cost (adjusted for inflation). This law directly affects pharmaceutical companies selling prescription drugs in Rhode Island and aims to curb unjustified price hikes.
Requires DCYF to implement recommendations made by the child advocate and child fatality review panel within 6 months and provide a report of the measures taken to address the recommendations.
Maddy summaryHB 5826 creates a new process allowing condominium associations to require written approval from unit mortgage holders (homeowners' lenders) for certain association actions, such as major repairs or budget changes. It specifies that associations must mail written requests to mortgage holders using recorded addresses, and if no written denial is received within 60 days, the approval is deemed granted. The bill explicitly states that mortgage holder approval cannot override basic association control over daily operations or affect litigation, insurance claims, or legal proceedings. This bill directly affects condo associations and their lenders, adding a formal step for certain decisions. The bill was introduced in February 2025 but withdrawn on March 4, 2025.
Maddy summaryHB 5980 amends state education funding to cover transportation costs for homeless students attending out-of-district public schools. It directly affects school districts that transport homeless students to non-public schools outside their district boundaries. The bill creates a dedicated funding stream to reimburse districts for these specific transportation expenses, with funds prorated if demand exceeds available funding. This provision aims to reduce financial burdens on districts serving homeless students while ensuring equitable access to education.
Restricts increases in monthly common expenses and limit special assessments to cover unforeseen costs not included in condo association’s approved annual budget for common expenses in associations where the minority of the units are deed-restricted units
Maddy summaryRhode Island's House of Representatives has passed HR 6023, a symbolic resolution proclaiming March 2025 as "Women's History Month" within the state. This resolution does not create new laws or affect any specific groups; it is a formal recognition of women's historical contributions. The resolution directs the Secretary of State to send certified copies to President Trump, Governor McKee, and Rhode Island's Congressional delegation. It aligns with the National Women's History Alliance's 2025 theme, "Moving Forward Together! Women Educating & Inspiring Generations," but does not implement any policy changes.
Allows on and after September 1, 2025, an owner of motor vehicle(s) to transfer ownership and registration of said vehicle on their death, by a certificate of title designation and requires DMV to amend title forms, to include transfer-on-death language.
Provides an 8% tax rate for those properties that are encumbered by a deed restriction for low-income housing set at 80% or 60% of adjusted median income established by HUD.
Maddy summaryHB 5626 requires most health insurance plans in the state to cover FDA-approved contraceptive drugs, devices, and related services without cost-sharing (like copays or deductibles). It directly affects individuals with health insurance plans by mandating coverage for specific methods - including emergency contraception, long-acting prescriptions (up to 12 months), sterilization, counseling, and follow-up care - while excluding male condoms and oral contraceptives without therapeutic equivalents. Insurers must cover at least one FDA-approved option per method category without cost-sharing, though they may offer multiple options with cost-sharing if one remains free. The law excludes experimental treatments and Medicare supplemental plans, and ensures coverage applies equally to spouses and dependents.